A detailed history of Armstrong Henry H Associates Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Armstrong Henry H Associates Inc holds 360,023 shares of JNJ stock, worth $55.9 Million. This represents 5.62% of its overall portfolio holdings.

Number of Shares
360,023
Previous 366,550 1.78%
Holding current value
$55.9 Million
Previous $53.6 Million 8.91%
% of portfolio
5.62%
Previous 5.37%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$145.48 - $167.38 $949,547 - $1.09 Million
-6,527 Reduced 1.78%
360,023 $58.3 Million
Q2 2024

Jul 02, 2024

SELL
$144.38 - $157.78 $1.22 Million - $1.34 Million
-8,474 Reduced 2.26%
366,550 $53.6 Million
Q2 2024

Jul 02, 2024

SELL
$144.38 - $157.78 $110,450 - $120,701
-765 Reduced 0.2%
375,024 $54.8 Million
Q1 2024

Apr 11, 2024

SELL
$155.22 - $162.74 $700,663 - $734,608
-4,514 Reduced 1.19%
375,789 $59.4 Million
Q4 2023

Jan 10, 2024

SELL
$145.6 - $158.88 $1.45 Million - $1.58 Million
-9,950 Reduced 2.55%
380,303 $59.6 Million
Q3 2023

Oct 16, 2023

SELL
$155.75 - $174.48 $471,143 - $527,802
-3,025 Reduced 0.77%
390,253 $60.8 Million
Q2 2023

Jul 10, 2023

SELL
$154.35 - $166.11 $1.11 Million - $1.2 Million
-7,208 Reduced 1.8%
393,278 $65.1 Million
Q1 2023

Apr 12, 2023

SELL
$151.05 - $180.26 $2 Million - $2.39 Million
-13,237 Reduced 3.2%
400,486 $62.1 Million
Q4 2022

Jul 10, 2023

BUY
$160.2 - $179.79 $2.12 Million - $2.38 Million
13,237 Added 3.31%
413,723 $73.1 Million
Q4 2022

Jan 09, 2023

SELL
$160.2 - $179.79 $819,423 - $919,625
-5,115 Reduced 1.22%
413,723 $73.1 Million
Q3 2022

Oct 12, 2022

BUY
$161.33 - $179.52 $382,029 - $425,103
2,368 Added 0.57%
418,838 $68.4 Million
Q2 2022

Jul 13, 2022

BUY
$168.19 - $186.01 $518,866 - $573,840
3,085 Added 0.75%
416,470 $73.9 Million
Q1 2022

Apr 27, 2022

SELL
$158.14 - $179.59 $881,314 - $1 Million
-5,573 Reduced 1.33%
413,385 $73.3 Million
Q4 2021

Jan 20, 2022

SELL
$155.93 - $173.01 $742,070 - $823,354
-4,759 Reduced 1.12%
418,958 $71.7 Million
Q3 2021

Oct 26, 2021

SELL
$161.5 - $179.47 $192,831 - $214,287
-1,194 Reduced 0.28%
423,717 $68.4 Million
Q2 2021

Jul 20, 2021

BUY
$159.48 - $171.07 $96,963 - $104,010
608 Added 0.14%
424,911 $70 Million
Q1 2021

Apr 20, 2021

SELL
$153.07 - $170.48 $187,357 - $208,667
-1,224 Reduced 0.29%
424,303 $69.7 Million
Q4 2020

Feb 01, 2021

SELL
$137.11 - $157.38 $605,340 - $694,832
-4,415 Reduced 1.03%
425,527 $67 Million
Q3 2020

Oct 26, 2020

SELL
$140.38 - $153.83 $467,886 - $512,715
-3,333 Reduced 0.77%
429,942 $64 Million
Q2 2020

Jul 22, 2020

SELL
$128.81 - $155.51 $132,545 - $160,019
-1,029 Reduced 0.24%
433,275 $60.9 Million
Q1 2020

May 05, 2020

BUY
$111.14 - $153.99 $443,559 - $614,574
3,991 Added 0.93%
434,304 $60 Million
Q4 2019

Jan 29, 2020

SELL
$127.5 - $146.44 $226,185 - $259,784
-1,774 Reduced 0.41%
430,313 $62.8 Million
Q3 2019

Oct 16, 2019

SELL
$126.95 - $142.14 $302,141 - $338,293
-2,380 Reduced 0.55%
432,087 $55.9 Million
Q2 2019

Jul 19, 2019

SELL
$131.15 - $144.24 $6.49 Million - $7.14 Million
-49,514 Reduced 10.23%
434,467 $60.5 Million
Q1 2019

Apr 16, 2019

SELL
$125.72 - $139.79 $1.04 Million - $1.15 Million
-8,244 Reduced 1.67%
483,981 $67.7 Million
Q4 2018

Jan 28, 2019

SELL
$122.84 - $147.84 $570,837 - $687,012
-4,647 Reduced 0.94%
492,225 $63.5 Million
Q3 2018

Oct 19, 2018

SELL
$121.58 - $142.88 $825,528 - $970,155
-6,790 Reduced 1.35%
496,872 $68.7 Million
Q2 2018

Jul 25, 2018

SELL
$119.4 - $131.76 $57,312 - $63,244
-480 Reduced 0.1%
503,662 $61.1 Million
Q1 2018

Apr 30, 2018

BUY
$125.1 - $148.14 $344,025 - $407,384
2,750 Added 0.55%
504,142 $65.8 Million
Q4 2017

Jan 23, 2018

BUY
$131.22 - $143.62 $270,969 - $296,575
2,065 Added 0.41%
501,392 $70.1 Million
Q3 2017

Oct 24, 2017

BUY
$129.47 - $135.38 $64.6 Million - $67.6 Million
499,327
499,327 $64.9 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Armstrong Henry H Associates Inc Portfolio

Follow Armstrong Henry H Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armstrong Henry H Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Armstrong Henry H Associates Inc with notifications on news.